Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.
复制标题
DOI:
10.1126/scisignal.2001450
复制
发表时间:
2011-07-05
影响因子:
7.3
通讯作者:
Xu HE
中科院分区:
文献类型:
--
作者:
He Y;Xu Y;Zhang C;Gao X;Dykema KJ;Martin KR;Ke J;Hudson EA;Khoo SK;Resau JH;Alberts AS;MacKeigan JP;Furge KA;Xu HE
The antimalaria drug chloroquine has been used as an anti-inflammatory agent for treating systemic lupus erythematosus and rheumatoid arthritis. We report that chloroquine promoted the transrepression of proinflammatory cytokines by the glucocorticoid receptor (GR). In a mouse collagen-induced arthritis model, chloroquine enhanced the therapeutic effects of glucocorticoid treatment. By inhibiting lysosome function, chloroquine synergistically activated glucocorticoid signaling. Lysosomal inhibition by either bafilomycin A1 (an inhibitor of the vacuolar adenosine triphosphatase) or knockdown of transcription factor EB (TFEB, a master activator of lysosomal biogenesis) mimicked the effects of chloroquine. The abundance of the GR, as well as that of the androgen receptor and estrogen receptor, correlated with changes in lysosomal biogenesis. Thus, we showed that glucocorticoid signaling is regulated by lysosomes, which provides a mechanistic basis for treating inflammation and autoimmune diseases with a combination of glucocorticoids and lysosomal inhibitors.
登录
查看更多内容
影响因子:
82.9
作者:
Chen, CD;Welsbie, DS;Sawyers, CL
通讯作者:
Sawyers, CL
影响因子:
12.3
作者:
Gentleman RC;Carey VJ;Bates DM;Bolstad B;Dettling M;Dudoit S;Ellis B;Gautier L;Ge Y;Gentry J;Hornik K;Hothorn T;Huber W;Iacus S;Irizarry R;Leisch F;Li C;Maechler M;Rossini AJ;Sawitzki G;Smith C;Smyth G;Tierney L;Yang JY;Zhang J
通讯作者:
Zhang J
影响因子:
64.8
作者:
DORN, A;STOFFEL, R;RIDLEY, RG
通讯作者:
RIDLEY, RG
影响因子:
64.5
作者:
CIECHANOVER, A;FINLEY, D;VARSHAVSKY, A
通讯作者:
VARSHAVSKY, A
影响因子:
--
作者:
Cho, SY;Kagan, BL;Simons, SS
通讯作者:
Simons, SS